TAIHO PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 1963-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.taiho.co.jp
A Study of TAS3731 in Healthy Adults
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 238
- Registration Number
- NCT05691660
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT05621447
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 126
- Registration Number
- NCT05335499
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Yokohama, Japan
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 78
- Registration Number
- NCT05245968
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, China
🇨🇳Fudan University, Shanghai Cancer Center, Shanghai, China
🇯🇵Kumamoto University Hospital, Kumamoto, Japan
AB122 Platform Study
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-11
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 715
- Registration Number
- NCT04999761
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Wakayama, Japan
Mass Balance Study of [14C] TAS-205 in Healthy Volunteers
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT04825431
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT04587908
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 231
- Registration Number
- NCT04512053
- Locations
- 🇯🇵
A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-07-30
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 91
- Registration Number
- NCT03605251
- Locations
- 🇯🇵
Taiho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 76
- Registration Number
- NCT03175029
- Locations
- 🇯🇵
Taiho Pharmaceutical Co., Ltd selected site, Kumamoto, Japan
© Copyright 2024. All Rights Reserved by MedPath